CALL - SPRINTER OPEN END - AMGEN | Market Closed - Deutsche Boerse AG 19:01:58 05/07/2024 BST | ||
| 9.54 EUR | +1.81% |
|
| Current month | -3.64% | ||
| 1 month | +0.63% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 9.54 | +1.81% |
| 04/07/24 | 9.37 | -1.06% |
| 03/07/24 | 9.47 | -2.27% |
| 02/07/24 | 9.69 | 0.00% |
| 01/07/24 | 9.69 | -2.12% |
Delayed Quote Deutsche Boerse AG
Last update July 05, 2024 at 07:01 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VV16X4 |
| ISIN | DE000VV16X45 |
| Date issued | 06/05/2022 |
| Strike | 208.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.48 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.49 € |
|---|---|
| Lowest since issue | 1.86 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9
USD
Average target price
316.4
USD
Spread / Average Target
+1.79%
- Stock Market
- Certificates
- Certificat
